[ad_1]
-
New CFO Appointed with Extensive Experience in Medical Technology and Public-Private Financing
-
Insulin Pump System Kaleido Expands Commercial Deployment Europe
Utrecht, Netherlands, February 1, 2023 /PR Newswire/ — ViCentra BV, company behind Kaleido, One of the World’s Smallest, Lightest and Most Accurate Insulin Pump Systems for Treating Type 1 Diabetes leo tools As Chief Financial Officer, I will provide an update of the company on Kaleido’s expansion path into key European markets in 2023.
leo tools He brings extensive experience in senior finance positions with over 25 years of experience in medical technology, pharmaceuticals and fast-moving consumer goods. Leo was previously CFO of hVIVO plc, an AIM & Euronext (HVO) listed UK contract research organization specializing in the testing of infectious and respiratory products, from 2020 to 2022. was CFO of Sigmoid Pharma Ltd, an Irish specialty pharmaceutical company developing medicines for the treatment of ulcerative colitis. 60 million Canadian dollars Leo’s other experience includes roles at BiancaMed Ltd, an Irish medical device company that was sold to ResMed Inc in 2011, and senior finance roles at Procter & Gamble. Europe.
French ChromeViCentra Chief Executive Officer said: “We are delighted to have Leo at a pivotal time in our company’s development and growth. He understands and has successfully led multiple private and public fundraising events.His expertise has enabled us to seek additional funding to expand our operations and with CE marked products. We will bring a kaleido to thousands of people with type 1 diabetes.”
leo toolsViCentra Chief Financial Officer commented: “I am thrilled to be joining ViCentra during this time of great change and growth for the company. I am very impressed with this disruptive technology that will help combat the diabetes epidemic. I look forward to contributing to the expansion of Kaleido and preparations for the US market.”
ViCentra’s flagship product, Kaleido, is one of the world’s smallest, lightest and most accurate insulin pump systems and is uniquely tailored to the user. This tiny pump combines the flexibility of a patch pump with the versatility of a traditional pump, using proprietary micropulse technology to deliver accurate and consistent insulin delivery. Available as a manual and automatic insulin delivery system.
ViCentra has successfully expanded its manufacturing capacity to launch Kaleido in multiple European regions and is expanding its commercial team. Kaleido is now available and Netherlands When France will be released in Germanywill be the world’s second largest diabetes market in 2023.
About Vicentra
ViCentra BV where the head office is located Utrecht, Netherlands It develops, manufactures and markets next-generation insulin pumps and other products to treat people with diabetes. The company’s flagship product is the Kaleido insulin pump, which is CE marked and marketed in European countries. This is his one of the world’s smallest, lightest and most accurate insulin pump systems, it’s waterproof, comes in 10 vibrant colors and is available as both a manual and automatic insulin infusion system. ViCentra was founded in 2013 and is backed by INKEF Capital, EQT Life Sciences, Health Innovations, Invest-NL, Partners in Equity and Kreos Capital. For more information on ViCentra, please visit www.hellokaleido.com.
View Original Content: https://www.prnewswire.com/news-releases/vicentra-bolsters-leadership-team-with-the-appointment-of-leo-toole-as-chief-financial-officer-and- expands-European commercialization-301735607.html
Source ViCentra
[ad_2]
Source link
